Loading...
8 Respiratory System Drugs Reports
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Boehringer Ingelheim, Merck & Co., AstraZeneca PLC, GlaxoSmithKline PLC, Grifols, S.A.
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi S.A, Lupin Limited, Cadila Healthcare Limited, Boehringer Ingelheim International GmbH, GlaxoSmithKline
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: GlaxoSmithKline Plc, Merck & Co Inc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Novartis AG
Study Period: 2021 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Regeneron Pharmaceuticals, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Novartis AG
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: HEALIOS K.K, Faron Pharmaceuticals, BioMarck Pharmaceuticals, Athersys, Apeptico Forschung
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific
Major Players: Mayne Pharma Group Limited, Hikma Pharmaceuticals plc, Lannett Company, Inc., GlaxoSmithKline, Teva Pharmaceutical Industries Ltd
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Merck KGaA , Koninklijke Philips NV, Fisher & Paykel Healthcare Limited, Resmed, Hamilton Company
Study Period: 2021- 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Cipla Inc. , Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, FibroGen, Inc., Horizon Therapeutics plc
Filter Reports
By Region
By Countries
